Clause,Predicted Labels,Confidences
"Made effective March 10, 2025, between NovaBio and HelixPath Research.",license grant,0.49
"NovaBio grants HelixPath a royalty-free, internal-use license for patented biomedical software.",license grant,0.98
"HelixPath commits to a minimum investment of $200,000 per year under this license.",minimum commitment,0.97
Governing law: State of Massachusetts.,governing law,0.96
"In the event of termination, HelixPath must return all licensed assets and delete derivative works.",post-termination services,0.97
